Skip to content

Finding the Optimal Location for Saturation Measurement During Flexible Bronchoscopy

Optimal Location of Saturation Measurement During Flexible Fiberoptic Bronchoscopy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03062137
Enrollment
116
Registered
2017-02-23
Start date
2017-01-01
Completion date
2017-03-30
Last updated
2017-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases, Desaturation of Blood

Keywords

bronchoscopy, saturation

Brief summary

An observational comparison of different locations of saturation measurements during Flexible Bronchoscopy

Detailed description

The study group will include 100 patients undergoing flexible fiberoptic bronchoscopy (FFB). The patients will receive sedation with Midazolam, Fentanyl and Propofol. All patients will receive supplemental oxygen via nasal cannula (2-4 L/min) before the beginning of the procedure. In all cases, patients will be monitored using continuous electrocardiography, pulse oximetry (on patients finger), and transcutaneous carbon dioxide and saturation (on patients earlobe), and automated noninvasive blood pressure recordings every 5 minutes. All parameters will be recorded from accepting patient to bed of procedure until 10 minutes after removal of FFB from nasopharynx. The saturation will be measured in 3 different locations (one pulse is added in other earlobe). additionally, A blood gas sample will be taken during discrepancy between different measurements. Immediately after the end of procedure, the measurements from 3 different monitors will be printed, and the blood sample be taken to a gas sample machine by the investigator. Desaturation value and time will be compared between the different locations. The blood arterial saturation will be compared to other measurements taken at the same time.

Interventions

DIAGNOSTIC_TESTblood gas sampling

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* informed consent

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Value changes between locationsThrough completion of bronchoscopy procedure an average of 30 minutesDifference of 10% of blood saturation between different locations during sedation for bronchoscopy procedure.
Time changes between locationsThrough completion of bronchoscopy procedure an average of 30 minutesThe level of desaturation of 90% is checked in the different monitors and the gap in seconds is registered

Secondary

MeasureTime frameDescription
gap between arterial gas sample and different monitorsThrough completion of bronchoscopy procedure an average of 30 minutesduring differences of more than 5% between finger and earlobe monitors we will take an arterial blood sample and the lab result will be compared to the measurements at the same time

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026